Syra Health Corp. (NASDAQ:SYRA) Short Interest Update

Syra Health Corp. (NASDAQ:SYRAGet Free Report) was the recipient of a large increase in short interest during the month of August. As of August 31st, there was short interest totalling 526,700 shares, an increase of 119.2% from the August 15th total of 240,300 shares. Approximately 12.0% of the shares of the company are sold short. Based on an average trading volume of 137,500 shares, the days-to-cover ratio is presently 3.8 days.

Syra Health Stock Up 2.3 %

Shares of SYRA traded up $0.01 during mid-day trading on Friday, hitting $0.44. 582,862 shares of the company traded hands, compared to its average volume of 324,789. The stock has a 50-day moving average price of $1.18 and a two-hundred day moving average price of $1.36. Syra Health has a 1 year low of $0.34 and a 1 year high of $8.37.

Syra Health (NASDAQ:SYRAGet Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported ($0.21) earnings per share for the quarter, missing the consensus estimate of ($0.19) by ($0.02). The firm had revenue of $1.97 million for the quarter, compared to the consensus estimate of $1.79 million. Syra Health had a negative net margin of 59.22% and a negative return on equity of 201.13%. Equities research analysts forecast that Syra Health will post -0.86 earnings per share for the current year.

Syra Health Company Profile

(Get Free Report)

Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions.

Further Reading

Receive News & Ratings for Syra Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syra Health and related companies with MarketBeat.com's FREE daily email newsletter.